Att 22_Schedule of Contract Prices.xlsx
XLSX spreadsheet 22 KB Posted
- Attached to
- NIDA Center for Genetic Studies Federal contract opportunity
- Solicitation number
- 75N95022R00097
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Amendment 01_Solicitation 75N95022R00097.docx | DOCX document | |
| Att 13_Wage Determination.pdf | ||
| Att 1_Packaging and Delivery of Proposals for Use with the NIH eCPS website.docx | DOCX document | |
| Att 4 - Property.pdf | ||
| Att 3 - SOW final.pdf | ||
| RFP_75N95022R00097.pdf | ||
| Att 21_Sample TO with Year 1 Contract Prices.pdf | ||
| Att 15_NIH(RC)2 Final.pdf | ||
| Att 15_Invoicing Instructions Without IPP Updated 8-15-22.docx | DOCX document | |
| Att 2_intent.pdf | ||
| Att 5_Section K.pdf |
Show all 11
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Pricing Schedule
| Schedule of Contract Prices | |||||||||||||||||
| Estimated Priced for the New Contract | |||||||||||||||||
| FY2023 Prices | FY2024 Prices | FY2025 Prices | FY2026 | FY2027 | |||||||||||||
| Item No. | Description of Service | Price Per Unit | Number of Units | Estimated Cost | Price Per Unit | Price Per Unit | Price Per Unit | Price Per Unit | |||||||||
| 1 | Receive Blood Shipment | 66 | $ - 0 | $ - 0 | 66 | $ - 0 | $ - 0 | 66 | $ - 0 | 66 | $ - 0 | 66 | $ - 0 | ||||
| 2 | DNA Extraction from Whole Blood | 2867 | $ - 0 | $ - 0 | 2,867 | $ - 0 | $ - 0 | 2,867 | $ - 0 | 2,867 | $ - 0 | 2,867 | $ - 0 | ||||
| 3 | DNA Extraction from Blood Spot Cards | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 4 | DNA Extraction from Saliva | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 5 | DNA Extraction from LCL | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 6 | RNA Extraction | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 7 | Transform Lymphocytes | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 8 | Plasma Isolation and Aliquoting | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 9 | Metabolic Assays for Total Cholesterol, HDL, and HbA1C | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 10 | Cryopreserve PBMCs | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 11 | Transform PBMCs | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 12 | Regrow LCLs | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 13 | Whole Genome Amplification | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 14 | Whole Genome Amplification Blood Spot Cards | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 15 | Whole Genome Amplification Serum | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||||||
| 16 | DNA Distribution Preparation | 16 | $ - 0 | $ - 0 | 16 | $ - 0 | $ - 0 | 16 | $ - 0 | 16 | $ - 0 | 16 | $ - 0 | ||||
| 17 | DNA Distribution in 96-well plates | 32 | $ - 0 | $ - 0 | 32 | $ - 0 | $ - 0 | 32 | $ - 0 | 32 | $ - 0 | 32 | $ - 0 | ||||
| 18 | DNA Shipment | 4 | $ - 0 | $ - 0 | 4 | $ - 0 | $ - 0 | 282 | $ - 0 | 282 | $ - 0 | 282 | $ - 0 | ||||
| 19 | LCL Distribution Preparation | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | |||||||||
| 20 | Cell Line Shipment | 1 | $ - 0 | $ - 0 | 1 | $ - 0 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | ||||
| 21 | RNA or WGA DNA Distribution | $ - 0 | $ - 0 | ||||||||||||||
| 22 | RNA Shipment | $ - 0 | $ - 0 | ||||||||||||||
| 23 | WGA DNA Shipment | $ - 0 | $ - 0 | ||||||||||||||
| 24 | Plasma Distribution | $ - 0 | $ - 0 | ||||||||||||||
| 25 | Plasma Shipment | $ - 0 | $ - 0 | ||||||||||||||
| 26 | Receipt Externally Producted LCLs (Culture, QC, mycoplasma test and verification) | $ - 0 | $ - 0 | ||||||||||||||
| 27 | Pedigree Relationships | $ - 0 | $ - 0 | ||||||||||||||
| 28 | External Mycoplasma Test | $ - 0 | $ - 0 | ||||||||||||||
| 29 | Storage of Plasma* | $ - 0 | |||||||||||||||
| 30 | Storage of Cryopreserved PBMC** | $ - 0 | |||||||||||||||
| 31 | Storage of LCL** | $ - 0 | |||||||||||||||
| 32 | Storage of LCL (Old NIDA)** | $ - 0 | |||||||||||||||
| 33 | Storage - DNA (Mechanical/Cuft)* | $ - 0 | |||||||||||||||
| 34 | Storage - Mechanical/per tube/year - DNA WB, DNA- LCL, Plasma | 180,000 | $ - 0 | 185000 | $ - 0 | $ - 0 | 185,000 | $ - 0 | 185,000 | $ - 0 | 185,000 | $ - 0 | |||||
| 35 | Storage - LN2/per ampule/year - LCL and Cryopreserved PBMC | 350,000 | $ - 0 | 355000 | $ - 0 | $ - 0 | 355,000 | $ - 0 | 355,000 | $ - 0 | 355,000 | $ - 0 | |||||
| 36 | Microarray - UK BioBanking - Budget based on 1000 | $ - 0 | $ - 0 | ||||||||||||||
| 37 | Microarray - Exome Array | $ - 0 | $ - 0 | ||||||||||||||
| 38 | Illumina Microarray(s) all platforms | 3,832 | $ - 0 | $ - 0 | $ - 0 | ||||||||||||
| 39 | Microarray and Genotyping - processing, licensing, and data management for Smokescreen**** | $ - 0 | $ - 0 | ||||||||||||||
| 40 | Microarray - SmokeScreen | ||||||||||||||||
| (chip / array)**** | $ - 0 | $ - 0 | |||||||||||||||
| 41 | Genotyping - processing, licensing, and data management for Smokescreen**** | $ - 0 | $ - 0 | ||||||||||||||
| 42 | Receive Blood Shipment - Only Bioinformatic and Inventory | $ - 0 | $ - 0 | ||||||||||||||
| 43 | Administrative, IT, and Database (Monthly Charge)*** | $ - 0 | $ - 0 | ||||||||||||||
| 44 | RNA Sequencing | $ - 0 | $ - 0 | ||||||||||||||
| RNA Sequencing (50M single end reads) @ 2x100bp | $ - 0 | $ - 0 | |||||||||||||||
| RNA Sequencing (80M single end reads) @ 2x100bp | $ - 0 | $ - 0 | |||||||||||||||
| 45 | Whole Genome Sequencing 30x******* | 162 | $ - 0 | $ - 0 | 162 | 162 | 162 | $ - 0 | |||||||||
| 46 | Whole Genome Sequencing 50x | $ - 0 | $ - 0 | $ - 0 | |||||||||||||
| 47 | Genomic Data Analysis | $ - 0 | $ - 0 | $ - 0 | |||||||||||||
| PACBio Library prep (15-20Kb) | $ - 0 | $ - 0 | $ - 0 | ||||||||||||||
| SMRT PacBio Seq all variant detection | $ - 0 | $ - 0 | $ - 0 | ||||||||||||||
| SMRT PacBio Seq Structural Variant detection | $ - 0 | $ - 0 | $ - 0 | ||||||||||||||
| SMRT whole transcriptome characterizing splicing with full length transcripts | $ - 0 | $ - 0 | $ - 0 | ||||||||||||||
| 20X Oxford Nanopore Whole Genome Sequencing with library prep | 160 | $ - 0 | $ - 0 | 160 | 160 | 160 | $ - 0 | ||||||||||
| Hi-C or Micro-seq per library | $ - 0 | ||||||||||||||||
| Cut and Run | $ - 0 | ||||||||||||||||
| ChipSeq | $ - 0 | ||||||||||||||||
| Whole Genome Bisulfate Sequencing | $ - 0 | ||||||||||||||||
| 48 | cDNA Synthesis and Storage | $ - 0 | |||||||||||||||
| 49 | cDNA Distribution Preparation | $ - 0 | |||||||||||||||
| 50 | cDNA Shipment | $ - 0 | |||||||||||||||
| 51 | RNA/cDNA archival | $ - 0 | |||||||||||||||
| 52 | iPSC Derivation-Reprogramming of Primary Lymphocytes: Sendai (NO QC): external source cells | $ - 0 | |||||||||||||||
| 53 | EP-iPSC Processing: per subclone-Receipt, expansion, and cryopreservation of one subclone from an iPSC line derived outside the RUCDR (20 ampules) | $ - 0 | |||||||||||||||
| 54 | IPSC-Quality Control and Characterization - Sendai persistence assay: QPCR assay to demonstrate loss of Sendai gene products | $ - 0 | |||||||||||||||
| 55 | IPSC-Quality Control and Characterization -RUID SNP (DNA extraction and SNP profiling): identity validation and tracking | $ - 0 | |||||||||||||||
| 56 | IPSC-Quality Control and Characterization - Basic iPSC characterization: Alkaline Phosphatase + Immunocytochemistry | $ - 0 | |||||||||||||||
| 57 | IPSC -Quality Control and Characterization - iPSC characterization by FACS: Oct-4 and Tra-1-60 pluripotency markers (others available upon request) | $ - 0 | |||||||||||||||
| 58 | IPSC - Quality Control and Characterization - Expression Array (Illumina HT12) analysis: includes RNA extraction, QC, and cDNA synthesis | $ - 0 | |||||||||||||||
| 59 | IPSC -Quality Control and Characterization - Embryoid body formation and characterization | $ - 0 | |||||||||||||||
| 60 | IPSC -Quality Control and Characterization - Karyotyping (G-banding) | $ - 0 | |||||||||||||||
| 61 | IPSC - Quality Control and Characterization - CNV analysis (Illumina OmniExpress arrays) | $ - 0 | |||||||||||||||
| 62 | IPSC - Quality Control and Characterization - Teratoma formation service: pricing available upon request | $ - 0 | |||||||||||||||
| 63 | Storage of iPS Cells | $ - 0 | |||||||||||||||
| 64 | Shipment of iPS Cells - Shipment of Cryopreserved | $ - 0 | |||||||||||||||
| 65 | Generation of Neural Stem Cells - Details available upon request | $ - 0 | |||||||||||||||
| 66 | ABCD Study Travel and Training***** | ||||||||||||||||
| 67 | Administrative, IT, and Database (Monthly Charge)*** | 12 | $ - 0 | 12 | $ - 0 | $ - 0 | 12 | $ - 0 | 12 | $ - 0 | 12 | $ - 0 | |||||
| 68 | DNA Extraction from Buffy Coat | $ - 0 | |||||||||||||||
| $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 |
| * | Storage price is included by aliquot in #33 Storage- Mechnical Storage. | ||
| ** | Storage price is included by aliquot in #34 Storage - LN2 Storage. | ||
| *** | Monthly charge for NCGS Administrative, IT, and Database Work for the NIDA Center for Genetic Studies. | Contract Year 1 | $ - 0 |
| **** | These prices are available with minimum order of 10,000 microarrays for ultimate genotyping over the life of the contract. | Contract Year 2 | $ - 0 |
| ***** | ABCD Study: Adolescent Brain and Cognitive Development Study. | Contract Year 3 | $ - 0 |
| ****** | Monthly Charge for Administrative Work for the ABCD Study | Contract Year 4 | $ - 0 |
| Contract Year 5 | $ - 0 | ||
| $ - 0 |
File details come from the government source that posted it. Updated .